Topic Archives: Pharmamar

Comments

  • Avatar

    Has anyone heard further info on ET-73? Received another email from Money Morning touting the "IPO", but I thought that ...

  • Avatar

    $PHM.MC/$PHMMF: Pharmamar an example of this Spanish revived renaissance in biotech: with the ingenuity of using molecu...

  • Avatar

    The company is PharmaMar working in conjunction with Johnson& Johnson Go to https://www.ncbi.nlm.nih.gov/pubmed/16...

  • Avatar

    Hi, Is there any news about the company behind the Nasdaq listing and ET-73? Is it Janssen Biotech or PharmaMar whose s...

  • Avatar

    Hi, Is there any news about the company behind the Nasdaq listing and ET-73? Is it Janssen Biotech or PharmaMar whose s...

  • Avatar

    Yes. The repair is based on tideglusib which is produced by a Spanish company called Noscira which is a divison of Zelti...

  • Avatar

    John, I'm still researching for this company. As I indicated in my blog from 8/29 in would appear that Janssen Products,...

  • Avatar

    This has been discussed on other threads it is PharmaMar.. PHMMF...

  • Avatar

    PharmaMar (Madrid) some facts: Its oncology portfolio has been validated through global partnerships, eg J&J in the...

  • Travis Johnson, Stock Gumshoe

    Yes, Pharmamar is getting some royalties from J&J for Yondelis. You can see their ...

  • Avatar

    I found this company as a PharmaMar after long research, How can we buy shares of this company. That I couldn't figure o...

  • Avatar

    from: http://www.edisoninvestmentresearch.com/research/report/pharmamar/preview/ "The former Zeltia Group has rest...

  • Avatar
  • Avatar

    Correction: PharmaMar...

  • Avatar

    Back in February I bought the US version of Pharmamar with symbol PHMMF. It tracks the Madrid version . I paid $2.60 an...

  • Avatar

    Wasn't there a recent reverse merger of the parent company (Zeltia) into the subsidiary (PharmaMar), which is the produc...

  • Avatar

    Another candidate is the Spanish company PharmaMar. They underwent a reverse merger 2 yrs ago with a paint-and-varnish c...

  • Avatar

    I want to buy pharmamar ipo at nasdaq How I can do this?...

  • Avatar

    The following, summarised from Edison research provides an overview of current status as per Edison: PharmaMar has bui...

  • Avatar

    A bit more to the point: J&J has the rights for distribution and sale in the U.S. So if you're expecting to cash i...

  • Avatar

    I am so tired of these hypesters like BH. The more someone hypes some investment that is not transparent to analysis, th...

  • Avatar

    Zeltia is the Spanish Parent. But their pharma involvement is small. I believe the Zeltia subsidiary PharmaMar USA i...

  • Avatar

    I'm new to Investing in Stocks all together. I don't want to have a disappointing Start in this Business. So anyone that...

  • Avatar

    Is there any additional risk to buying PharmaMar off the Spanish stock exchange now as opposed to buying pre NASDAQ ipo ...

  • Avatar

    Pharmamar, as of this writing, is trading at 1.99 Euro, or 2.21 USD per share. As I understand the pre-IPO offer via Fi...

  • Avatar

    The two previous comments are correct Pharmamar or Pharma Mar is the company, symbol PHM.MC on the Madrid exchange. That...

  • Avatar

    I found this abstract write up on Trabectedin: Ecteinascidin 743. I also saw this reference to a new NASDAQ filing a ...

  • Avatar
  • Avatar

    Probably is this medicament http://www.yondelis.com/ to the spanish group PHARMA MAR R (PHM.MC) and Janssen. In the spa...

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

    Connect with Travis

    website designed by Gravity Switch